Safety

Products

KIRO® Oncology
KIRO® Fill

KIRO® Oncology

“ Robotic compounding is expected to decrease the global risk of failures due to less human intervention in some critical tasks(16)”

 

Patient Safety:
✓

Robotic compounding compared to manual compounding significantly reduces compounding error rates (1,11%) (9%) from a total of 52.852 IV chemotherapy doses(19)

✓

Increases patient safety through enhanced accuracy(19)

User Safety:
✓

Decreased chemotherapy waste and drug exposure for employees(19)

✓

Significantly reduced chemical risk by decreasing workplace contamination level(14)

✓

Potential role avoiding stress injuries related to the use of high-volume syringes(16)

 

KIRO® Fill

“Satisfactory results when compounding sterile preparations using KIRO® Fill and positive feedback received from nurses, have led us to incorporate new batches, such as morphine syringes(31)”

 

✓

The average dose accuracy errors for syringes (n=2813) and infusion bags (n=395) were 0,23% and -0,09%, respectively(31)

✓

Results from sterility tests demonstrated the absence of microbial growth in all tested preparations(31)

✓

Operator’s safety is guaranteed as the drug levels measured in environmental air are below the OEL (Occupational Exposure Limits)(28)

✓

The results demonstrate that the automatic compounding of sensitizing drugs in KIRO® Fill ensures patient’s safety by avoiding cross-contamination of drugs in subsequent compounded batches(28)

✓

The results show that the use of Kiro Fill avoid adverse reactions in patients with hypersensitivity to β-lactam antibiotics and other drugs(28)